2026/04/22 by Ayaaz Habib, Saibal Das, Narendra Siddaiah +1
paper · doi:10.1017/s0022215126104770
crossref issued 2026/04/22 · crossref published 2026/04/22 · crossref published-online 2026/04/22 · crossref created 2026/04/22 · crossref deposited 2026/07/08 · crossref indexed 2026/07/30
Abstract Objectives This study aimed to evaluate outcomes of a high-throughput tonsillectomy pathway using the BiZact™ device and consider its applicability in National Health Service practice. Methods A prospective service evaluation was undertaken in a UK teaching hospital (April–July 2023). Fifty consecutive patients underwent BiZact™ tonsillectomy across five morning lists. Data included demographics, operative time, blood loss, post-tonsillectomy haemorrhage, pain and satisfaction. Results Fifty patients (15 male, 35 female; mean age 24.6 years) underwent surgery. Indications were recurrent tonsillitis (86 per cent), asymmetry (10 per cent) and tonsilloliths (4 per cent). Mean operative time was 5 minutes; blood loss less than 10 ml. No primary haemorrhage occurred. Secondary post-tonsillectomy haemorrhage occurred in 5/50 (10 per cent): 3/48 adults (6.3 per cent) and 2/2 adolescents; three required return to theatre. Of 33 patients completing follow-up, 70 per cent reported severe pain. Four (8 per cent) reattended for analgesia. Waiting time fell from ∼40 weeks to ∼two weeks. Conclusion BiZact™ enabled efficient list turnover but with higher post-tonsillectomy haemorrhage rates, likely reflecting a learning curve.